Remove Genome Project Remove Medicine Remove Vaccine
article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

A 2022 study from the Royal College of Physicians and British Pharmacological Society demonstrated the potential of pharmacogenomics, with scientists identifying the genetic cause behind an individual’s drug response for over forty medicines.

Genome 129
article thumbnail

Hong Kong reports 'first case' of virus reinfection

The Pharma Data

. “This is a very rare example of reinfection,” said Brendan Wren, professor of microbial pathogenesis, at London School of Hygiene and Tropical Medicine. “And it should not negate the global drive to develop Covid-19 vaccines. “It is to be expected that the virus will naturally mutate over time.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Genomic projects exploit scale as clinical applications play catch-up

Pharmaceutical Technology

The group analysed 12,222 samples collected through whole genome sequencing efforts of the UK National Health Service as part of the 100,000 Genomes Project and added further data on 6,418 cancers from the International Cancer Genome Consortium and the Hartwig Medical Foundation. Both teams had the same underlying goal.

article thumbnail

The Biotech Effect

Pharmaceutical Technology

As understanding of biological systems has forged ahead, pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines. It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals.

Antibody 100